Functional characterization of 23 allelic variants of thiopurine S-methyltransferase gene (TPMT*2 - *24)

Pharmacogenetics and Genomics
Shuta UjiieMasahiro Hiratsuka

Abstract

Thiopurine S-methyltransferase (TPMT) is an enzyme responsible for the detoxification of the widely used thiopurine drugs. TPMT is genetically polymorphic and is associated with large interindividual variations in thiopurine drug toxicity and therapeutic efficacy. In this study, we performed an in-vitro analysis of TPMT variant alleles, namely, TPMT*2, *3A, *3B, *3C, *5, *6, *7, *8, *9, *10, *11, *12, *13, *14, *16, *17, *18, *19, *20, *21, *22, *23, and *24. The wild-type TPMT proteins, TPMT.1 and 23 variants were heterologously expressed in COS-7 cells, and the kinetic parameters Km, Vmax, and intrinsic clearance (Vmax/Km) of 6-thioguanine S-methylation were determined. The expression levels of TPMT.2, TPMT.3A, TPMT.5, TPMT.12, TPMT.14, and TPMT.22 were considerably lower than that of TPMT.1 (P<0.005), and that of TPMT.18 was slightly reduced (P<0.05). The kinetic parameters of TPMT.3A, TPMT.3B, TPMT.5, TPMT.14, TPMT.18, TPMT.21, and TPMT.22 could not be accurately established because of no activity in 6-thioguanine S-methylation. The Vmax/Km values of TPMT.2, TPMT.7, TPMT.17, and TPMT.24 were displayed less than 10% of the wild-type. This functional analysis with respect to TPMT variants could provide useful information for ...Continue Reading

References

Sep 1, 1992·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·R M Weinshilboum
Jan 1, 1992·European Journal of Clinical Pharmacology·L Lennard
Nov 29, 1994·Biochemical Pharmacology·M DeiningerR M Weinshilboum
May 20, 1999·Annual Review of Pharmacology and Toxicology·R M WeinshilboumC L Szumlanski
Feb 7, 2003·The New England Journal of Medicine·Richard Weinshilboum
Sep 19, 2003·Biochemical and Biophysical Research Communications·Rima Hamdan-KhalilFranck Broly
Jun 22, 2005·Proceedings of the National Academy of Sciences of the United States of America·Liewei WangRichard M Weinshilboum
Oct 13, 2005·Pharmacogenetics and Genomics·Oreste E SalavaggioneRichard M Weinshilboum
Sep 2, 2006·Drug Metabolism and Pharmacokinetics·Takamitsu SasakiMichinao Mizugaki

❮ Previous
Next ❯

Citations

Nov 12, 2010·European Journal of Clinical Pharmacology·Roberta RussoUNKNOWN TEDDY European Network of Excellence
Oct 3, 2012·Journal of Biomolecular Structure & Dynamics·Sofiene LarifKamel Bouraoui
Feb 16, 2010·Pharmacogenetics and Genomics·Liewei WangTeri E Klein
Aug 12, 2009·Pharmacogenomics·Natasa Karas-Kuzelicki, Irena Mlinaric-Rascan
Mar 20, 2010·Pharmacogenomics·Melissa A SmithJeremy D Sanderson
Jul 30, 2010·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Petra JancovaEva Anzenbacherova
Feb 15, 2013·Pharmacogenetics and Genomics·Malin L AppellSally A Coulthard
Aug 10, 2015·Clinical Pharmacokinetics·Mehmet CoskunOle Haagen Nielsen
Oct 6, 2012·Pediatric Clinics of North America·Michael Rieder
Sep 28, 2015·Computational Biology and Chemistry·Esmat Fazel-NajafabadiMaryam Sedghi
Jan 27, 2016·Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology·Farida H El-RashedyShaymaa A Temraz
Aug 8, 2009·British Journal of Clinical Pharmacology·Shirley Kow Yin KhamAllen Eng Juh Yeoh
Feb 13, 2013·Journal of Clinical Pharmacology·Lara ColleoniPia Bernasconi
Jan 26, 2010·Biochemical Pharmacology·Alan Kambiz FotoohiFreidoun Albertioni
Mar 27, 2012·Drug Metabolism and Pharmacokinetics·Chun Kiat LeeEvelyn Siew-Chuan Koay
Sep 13, 2016·International Journal of Molecular Sciences·Vid MlakarMarc Ansari
Mar 8, 2018·Clinical Pharmacokinetics·Luc J J DerijksAdriaan A van Bodegraven
May 21, 2014·The American Journal of Gastroenterology·Mahmoud H MosliBrian G Feagan
Jan 31, 2019·Journal of Crohn's & Colitis·Reinier L SluiterMarieke J H Coenen
Sep 1, 2017·European Journal of Gastroenterology & Hepatology·Constantina CoucoutsiElias A Kouroumalis
Jun 3, 2016·Current Opinion in Pulmonary Medicine·Justin M OldhamFernando J Martinez
Sep 21, 2012·Expert Review of Clinical Immunology·Ibrahim IbrahimAnne Barton
Nov 10, 2015·BMC Genomics·Manuel CorpasPeter N Robinson
Dec 12, 2020·Pharmacogenomics·Bianca Jc van den Bosch, Marieke Jh Coenen
Aug 14, 2020·Drug Metabolism and Pharmacokinetics·Shotaro UeharaHiroshi Yamazaki

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.